Litigation: SEC Vs. Applied BioSciences Corp. - SEC Obtains Final Judgment Against Company for Misleading Covid-19-Related Claims
December 08, 2020
December 08, 2020
WASHINGTON, Dec. 8 -- The Securities and Exchange Commission issued the following litigation release (No. 20-cv-03729; S.D.N.Y. filed May 14, 2020):
On December 4, 2020, the U. S. District Court for the Southern District of New York entered a final judgment against Applied BioSciences Corp. in connection with the company's fraudulent claims in a press release that it was offering and shipping products to combat the COVID-19 virus.
As alleged in the Commission's complain . . .
On December 4, 2020, the U. S. District Court for the Southern District of New York entered a final judgment against Applied BioSciences Corp. in connection with the company's fraudulent claims in a press release that it was offering and shipping products to combat the COVID-19 virus.
As alleged in the Commission's complain . . .